Skip to main content
News Icon

News categories: Honors & Funding

Acute lymphoblastic leukemia in children

Joint research project on early detection and interception "EDI-4-ALL" recieves BMBF funding

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and poses a significant threat to health. The joint research project "EDI-4-ALL" (Early detection and interception for acute lymphoblastic leukemia) aims at the development of new analysis tools for the early detection of a genetic predisposition to ALL in newborns. The project is a joint endeavour by leading scientists from the Universities of Düsseldorf, Gießen and Bonn, the Charité Berlin and Zytovision, under participation of ImmunoSensation2 member Prof. Aleksandra Pandyra. The project is funded with a total of 2.6 million Euros by the BMBF.

With a factor of 100:1, the genetic predisposition for ALL is significantly more common than the actual disease. Hence, the scientists that joined forces under the umbrella of EDI-4-All aim to identify the risk factors that promote the progression from a predisposition to leukemia to actual full-blown leukemia. To this end, a new high-throughput method is to be developed, which will enable screening of umbilical cord blood from 3,000 newborns. In addition, microbiome samples from the children and epidemiological data will be analyzed and evaluated using artificial intelligence.

To reach this goal, EDI-4-ALL unites leading experts and institutions. The University Hospital Düsseldorf (Dr. Ute Fischer, Dr. Melina Mescher, Prof. Arndt Borkhardt and Prof. Dr. Gesine Kögler), Charité - Universitätsmedizin Berlin (PD Dr. Cornelia Eckert), ZytoVision GmbH (Dr. Britta Meyer, Bremerhaven), the German Cancer Research Center (Dr. David Koppstein, Heidelberg), Justus Liebig University Giessen (Prof. Dr. Stefan Janssen), the University of Bonn and the University Hospital Bonn (Prof. Dr. Aleksandra Pandyra) are collaborating internationally with one of the largest maternity clinics in Spain, BCNatal in Barcelona (Prof. Dr. Eduard Gratacos), and the International Agency for Research on Cancer of the World Health Organization, IARC/WHO in Lyon (Dr. Joachim Schüz). The Löwenstern e.V. (Dr. Friedhelm Schuster), an association for the benefit of children with cancer, is supporting the project from the perspective of affected patients and their parents. 
 

The project is part of the National Decade against Cancer and is funded by the Federal Ministry of Education and Research (BMBF) with a total of over 2.6 million euros. With the successful implementation of EDI-4-ALL, important progress could be made in risk-adapted early detection of cancer. The quality of life of affected children could be sustainably improved by identifying the predisposition to leukemia in newborns at an early stage and preventing it from developing into full-blown cancer in childhood.
 

Contact

Dr. Ute Fischer

Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Düsseldorf University Hospital

Tel.: 0211 81-16339

 ute.fischer@med.uni-duesseldorf.de

 

 

Prof. Aleksandra Pandyra

Clinical Chemistry and Clinical Pharmacology

University Hospital Bonn

+49 228 287 51971

apandyr1@uni-bonn.de

Related news

Cummings Center announcment group photo

News categories: Honors & Funding

Cooperation with the Cumming Global Centre

The Cumming Global Centre for Pandemic Therapeutics (Cumming Global Centre) and the University of Bonn have today announced Bonn-Cumming Host-Directed Pandemic Therapeutics Research Program (“the partnership”) to fund groundbreaking research into early immunity to develop novel targets for therapeutics for pathogens of pandemic potential. The funding volume amounts to 6 million euros, with a perspective of up to 40 million euros. A large part comes from the philanthropic billionaire Geoff Cumming.
View entry
Plastic bottles

News categories: Honors & Funding

Effects of “Forever Chemicals” on the Immune System

Dr. Lorenzo Bonaguro from the German Center of Neurodegenerative Dieseases (DZNE) has been awarded a Starting Grant from the European Research Council (ERC) totaling about 1.5 million euros to investigate the influence of the ubiquitous PFAS chemicals on the immune system. His research will utilize so-called organoids and cutting-edge analysis methods.
View entry
Csm Bradke header 498bf3128b

News categories: Honors & Funding

Berlin-Brandenburg Academy of Science Honors Bonn Neurobiologist

Neurobiologist Frank Bradke, a research group leader at DZNE and professor at the University of Bonn, has been awarded the 50,000 euro Academy Prize of the Berlin-Brandenburg Academy of Sciences and Humanities. The award recognizes his outstanding scientific accomplishments in the field of neuronal development and regeneration. With his studies, the Bonn scientist, who focuses on fundamental mechanisms, aims to pave the way for a better treatment of spinal cord injuries. In recent years, Bradke has already been recognized with several awards for his exceptional research.
View entry

Back to the news overview